Kate Fletcher

3.0k total citations · 1 hit paper
40 papers, 2.2k citations indexed

About

Kate Fletcher is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Kate Fletcher has authored 40 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 17 papers in Epidemiology and 10 papers in Economics and Econometrics. Recurrent topics in Kate Fletcher's work include Acute Ischemic Stroke Management (12 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Blood Pressure and Hypertension Studies (8 papers). Kate Fletcher is often cited by papers focused on Acute Ischemic Stroke Management (12 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Blood Pressure and Hypertension Studies (8 papers). Kate Fletcher collaborates with scholars based in United Kingdom, Australia and United States. Kate Fletcher's co-authors include Jonathan Mant, Richard Hobbs, Andrea Roalfe, Gregory Y.H. Lip, David Fitzmaurice, Ellen Murray, Richard J. McManus, Pelham Barton, R Holder and Paul Glasziou and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Kate Fletcher

39 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

2007 1.1k citations Jonathan Mant, Richard Hobbs et al. The Lancet profile →

Peers

Countries citing papers authored by Kate Fletcher

Since Specialization

Citations

This map shows the geographic impact of Kate Fletcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate Fletcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate Fletcher more than expected).

Fields of papers citing papers by Kate Fletcher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate Fletcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate Fletcher. The network helps show where Kate Fletcher may publish in the future.

Co-authorship network of co-authors of Kate Fletcher

This figure shows the co-authorship network connecting the top 25 collaborators of Kate Fletcher. A scholar is included among the top collaborators of Kate Fletcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate Fletcher. Kate Fletcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prevention and treatment of venous thromboembolism in hospital and the community: a research programme including the ExACT RCT 2020 ·SHILAP Revista de lepidopterología ·David Fitzmaurice, Kate Fletcher, Sheila Greenfield, Sue Jowett, Alison Ward, Carl Heneghan, E. Knight, Chris Gardiner, Andrea Roalfe, Yongzhong Sun, Pollyanna Hardy, Deborah McCahon, (unknown), (unknown), Richard Hobbs	1
2	A randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post‐thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study) 2019 ·British Journal of Haematology ·Charlotte Bradbury, Kate Fletcher, Yongzhong Sun, Carl Heneghan, Chris Gardiner, Andrea Roalfe, Pollyanna Hardy, (unknown), (unknown), (unknown), Richard Hobbs, David Fitzmaurice	22
3	Prevention of excessive hypothermia in infants with hypoxic ischemic encephalopathy prior to admission to a quaternary care center: a neonatal outreach educational project 2019 ·Journal of Perinatology ·(unknown), Hong Huang, Kate Fletcher, Peter J. Giannone	3
4	Treatment of fatigue with physical activity and behavioural change support in vasculitis: study protocol for an open-label randomised controlled feasibility study 2018 ·BMJ Open ·Lorraine Harper, Matthew D. Morgan, Dimitrios Chanouzas, (unknown), (unknown), Caroline Dean, Kate Fletcher, Fiona Cramp, Sheila Greenfield, Catherine A Hewitt, Natalie Ives, Sue Jowett, Amanda Daley	15
5	Cost-effectiveness analysis of use of a polypill versus usual care or best practice for primary prevention in people at high risk of cardiovascular disease 2017 ·PLoS ONE ·Sue Jowett, Pelham Barton, Andrea Roalfe, Kate Fletcher, Richard Hobbs, Richard J. McManus, Jonathan Mant	20
6	AN ASSESSMENT OF THE VALIDITY AND RESPONSIVENESS OF THE ICECAP-O IN A MULTICENTRE RANDOMIZED CONTROLLED TRIAL OF BLOOD PRESSURE MANAGEMENT 2016 ·Value in Health ·(unknown), Hareth Al‐Janabi, Kate Fletcher, Richard J. McManus, Jonathan Mant, Joanna Coast	1
7	Patients' views about taking a polypill to manage cardiovascular risk: a qualitative study in primary care. 2015 ·Apollo (University of Cambridge) ·Satnam Virdee, Sheila Greenfield, Kate Fletcher, Richard J. McManus, Jonathan Mant	15
8	Visceral Leishmaniasis and Immunocompromise as a Risk Factor for the Development of Visceral Leishmaniasis: A Changing Pattern at The Hospital for Tropical Diseases, London 2015 ·PLoS ONE ·Kate Fletcher, Rita Issa, Diana N.J. Lockwood	20
9	RCT of different systolic blood pressure targets for people with a history or stroke or transient ischaemic attack: the PAST-BP (Prevention After Stroke - Blood Pressure) study 2014 ·Journal of Human Hypertension ·Jonathan Mant, Richard J. McManus, (unknown), Kate Fletcher, (unknown), Una Martin, Satnam Virdee, Sheldon Greenfield, Richard Hobbs	4
10	Attending coroner's court: a practical guide 2013 ·British Journal of Hospital Medicine ·Kate Fletcher, (unknown)	0
11	Would primary healthcare professionals prescribe a polypill to manage cardiovascular risk? A qualitative interview study 2013 ·BMJ Open ·Satnam Virdee, Sheila Greenfield, Kate Fletcher, Richard J. McManus, Richard Hobbs, Jonathan Mant	26
12	The impact of telehealth support for patients with diabetes orchronic obstructive pulmonary disease on unscheduled secondary careutilisation: a service evaluation 2013 ·Journal of Innovation in Health Informatics ·Andrew Lee, Simon Oliver, Kate Fletcher, Jean Robinson	2
13	RApid Primary care Initiation of Drug treatment for Transient Ischaemic Attack (RAPID−TIA): study protocol for a pilot randomised controlled trial 2013 ·Trials ·Duncan Edwards, Kate Fletcher, (unknown), Richard J. McManus, Daniel Lasserson, Matthew F. Giles, Don Sims, John Norrie, (unknown), Simon Cohn, (unknown), (unknown), Christopher J. Weir, Jonathan Mant	5
14	A 12-Week Commercial Web-Based Weight-Loss Program for Overweight and Obese Adults: Randomized Controlled Trial Comparing Basic Versus Enhanced Features 2012 ·Journal of Medical Internet Research ·Clare E. Collins, Philip J. Morgan, (unknown), Kate Fletcher, Julia E. Martin, Elroy J. Aguiar, (unknown), Melinda Neve, Robin Callister	82
15	Development and Initial Validation of a Simple Clinical Decision Tool to Predict the Presence of Heart Failure in Primary Care: The MICE (Male, Infarction, Crepitations, Edema, MICE) Rule 2012 ·European Journal of Heart Failure ·Andrea Roalfe, Jonathan Mant, Jenny Doust, Pelham Barton, Martín Cowie, Paul Glasziou, David Mant, Richard J. McManus, Roger Holder, Jonathan J Deeks, Robert N. Doughty, Arno W. Hoes, Kate Fletcher, Richard Hobbs	22
16	Impact of age and sex on primary preventive treatment for cardiovascular disease in the West Midlands, UK: cross sectional study 2012 ·BMJ ·James P Sheppard, Surendra Prasad Singh, Kate Fletcher, Richard J. McManus, Jonathan Mant	55
17	A cross-sectional study of quality of life in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation Treatment of the Aged study 2012 ·EP Europace ·Andrea Roalfe, (unknown), (unknown), (unknown), Shahryar Saba, Kate Fletcher, Gregory Y.H. Lip, Richard Hobbs, Jonathan Mant, (unknown)	23
18	Evaluation of a commercial web-based weight loss and weight loss maintenance program in overweight and obese adults: a randomized controlled trial 2010 ·BMC Public Health ·Clare E. Collins, Philip J. Morgan, (unknown), Kate Fletcher, Julia E. Martin, Elroy J. Aguiar, (unknown), Melinda Neve, Patrick McElduff, Robin Callister	35
19	Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial breakdown → 2007 ·The Lancet ·Jonathan Mant, Richard Hobbs, Kate Fletcher, Andrea Roalfe, David Fitzmaurice, Gregory Y.H. Lip, Ellen Murray	1097
20	Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269] 2003 ·BMC Cardiovascular Disorders ·(unknown), Suzanne H Richards, Richard Hobbs, David Fitzmaurice, Gregory Y.H. Lip, Ellen Murray, Miriam Banting, Kate Fletcher, Joy K Rahman, Teresa Allan, James Raftery, Stirling Bryan	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact